Tandem Diabetes Care
TNDM
90 hedge funds and large institutions have $165M invested in Tandem Diabetes Care in 2016 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 32 increasing their positions, 27 reducing their positions, and 12 closing their positions.
19% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 27
17% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 12
1% more funds holding
Funds holding: 89 → 90 (+1)
26% less capital invested
Capital invested by funds: $222M → $165M (-$57.8M)
89% less call options, than puts
Call options by funds: $590K | Put options by funds: $5.4M
Top Buyers
Top Sellers
| 1 |
HM
HealthCor Management
New York
|
-$2.3M |
| 2 |
Westfield Capital Management
Boston,
Massachusetts
|
-$1.87M |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$1.75M |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$1.18M |
| 5 |
PVI
Pura Vida Investments
New York
|
-$979K |
TNDM Hedge Fund Activity: Q1 2016 in Review
90 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q1 2016, worth a combined $165M — down 26% from $222M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new TNDM positions and 12 closed out — a net gain of 2 holders — while 32 added to existing stakes and 27 trimmed.
The largest buyer was Sectoral Asset Management, opening a new position worth an estimated $2.35M. The largest seller was HealthCor Management, exiting entirely with an estimated $2.3M sold.
- 90 institutional investors held Tandem Diabetes Care (TNDM) as of Q1 2016, up from 89 in Q4 2015.
- Funds reported $165M of Tandem Diabetes Care stock for Q1 2016, down 26% quarter-over-quarter.
- 14 funds opened new Tandem Diabetes Care positions in Q1 2016 and 12 closed out, a net change of +2 holders.
- The largest Tandem Diabetes Care buyer in Q1 2016 was Sectoral Asset Management, an estimated $2.35M added.
- The largest Tandem Diabetes Care seller in Q1 2016 was HealthCor Management, an estimated $2.3M sold.
Based on aggregated 13F filings for Q1 2016.